...
首页> 外文期刊>The Internet Journal of Anesthesiology >Successful Therapy Of Phantom Pain In The Upper Limb By Blocking The Brachial Plexus
【24h】

Successful Therapy Of Phantom Pain In The Upper Limb By Blocking The Brachial Plexus

机译:通过阻塞臂丛成功治疗上肢幻影痛

获取原文

摘要

Early treatment of phantom limb pain in patients after amputation reduces the incidence of chronic pain sensations from 60 - 85 % to 10 - 20 % [1]. A 33 year old patient with osteosarcoma of proximal humerus developed a burning pain VAS 7-8 (Visual analog scale 0-10) of the left hand and fingers three days after amputation of the left arm in the shoulder joint. Treatment with calcitonin, amitriptyline, naproxen, piritramide and carbamazepine did not influence the pain. On the seventh day an interscalene block was done with the use of a nerve stimulator. After a bolus of 30 ml ropivacaine 0.2 % was infused with a rate of 6 ml/h for ten days. Within a time period of ten minutes the phantom limb pain was relieved (VAS 0). After four hours phantom limb sensations developed, but were not classified as pain by the patient. With the option of a patient controlled bolus of 5 ml (2x /h) it was possible to reduce the additional pain therapy to carbamazepine and amitriptyline. During the ropivacaine treatment no motor blockade or other side effects were observed. After ten days the catheter site showed minor signs of inflammation and the catheter was removed. In an early follow-up (5 month) the patient reported mild phantom limb sensations and infrequent phantom pain (VAS 1-2), no analgesic medication was necessary. Interscalene block provided comfortable and safe analgesia for this patient and helped to avoid development of chronic phantom limb pain. A comparable therapy using bupivacaine would have led to toxic plasma concentrations. Ropivacaine is not only less toxic (16), it also provides the advantage of a less intensive motor blockade (17), limiting the danger of phrenic nerve block.
机译:截肢后患者幻肢痛的早期治疗将慢性疼痛感的发生率从60-85%降低到10-20%[1]。一名33岁的肱骨近端骨肉瘤患者在左臂截肢后三天出现了左手和手指的烧灼痛VAS 7-8(视觉模拟量表0-10)。降钙素,阿米替林,萘普生,吡咯酰胺和卡马西平治疗均不影响疼痛。在第七天,使用神经刺激器进行肌间沟阻断。推注30 ml罗哌卡因后,以6 ml / h的速度注入0.2%,持续十天。在十分钟的时间内,幻肢疼痛得到缓解(VAS 0)。四小时后,幻象肢体感觉发展,但未被患者归类为疼痛。通过患者控制的5毫升推注剂量(2x / h),可以减少卡马西平和阿米替林的额外疼痛治疗。罗哌卡因治疗期间未观察到运动阻滞或其他副作用。十天后,导管部位显示出轻微的炎症迹象,将导管拔出。在早期随访(5个月)中,患者报告有轻微的幻肢感觉和幻象疼痛(VAS 1-2)不多,因此无需镇痛药。肌间沟素阻滞剂为该患者提供了舒适安全的镇痛药,并有助于避免出现慢性幻肢痛。使用布比卡因的类似疗法会导致血浆中毒浓度升高。罗哌卡因不仅毒性较低(16),而且还具有较低的运动阻滞(17)优势,限制了nerve神经阻滞的危险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号